TA, N., AT, N., LV, D., HB, N., HD, V., TNB, N., . . . JC, A. (2026). Saliva point-of-care testing for suboptimal levofloxacin and linezolid exposure in multidrug-resistant tuberculosis. The European respiratory journal, 67(6), . https://doi.org/10.1183/13993003.01875-2025
Chicago Style (17th ed.) CitationTA, Nguyen, et al. "Saliva Point-of-care Testing for Suboptimal Levofloxacin and Linezolid Exposure in Multidrug-resistant Tuberculosis." The European Respiratory Journal 67, no. 6 (2026). https://doi.org/10.1183/13993003.01875-2025.
MLA (9th ed.) CitationTA, Nguyen, et al. "Saliva Point-of-care Testing for Suboptimal Levofloxacin and Linezolid Exposure in Multidrug-resistant Tuberculosis." The European Respiratory Journal, vol. 67, no. 6, 2026, https://doi.org/10.1183/13993003.01875-2025.